Dutch and US researchers have re-engineered non-druggable compounds that block the transmission and ...
Up To Date
Latest News
Swiss Versantis AG has raised money in order to advance its liver detoxifying candidate VS-01 from ongoing...
Danish Lundbeck AS is has secured a stake in the migraine market by paying US$1.95bn (€1.76bn) to acquire...
Prague-based PPF Group has acquired a 19.2% stake in Autolus Therapeutics plc, a developer of T cell cancer...
German and US researchers have found a biomarker that identifies tumours responding to CTLA-4 checkpoint...
French biotech Inotrem SA raised €39m to finance Phase IIb efficacy testing of its TREM1 blocker nangibotide...
Share
